CareView Communications (CRVW) Gains from Investment Securities (2015 - 2016)
CareView Communications' (CRVW) quarterly Gains from Investment Securities came in at -$2335.0 in Q4 2016, up 97.64% year-over-year from -$1181.5 in Q1 2016, and up 73.53% quarter-over-quarter from -$8821.0 in Q3 2016.
Powered by 
Analysis
CareView Communications (CRVW) Gains from Investment Securities (2015 - 2016) Analysis & Trends
CareView Communications has disclosed Gains from Investment Securities across 2 years of filings, most recently posting -$2335.0 for Q4 2016.
- In Q4 2016, Gains from Investment Securities rose 97.64% year-over-year to -$2335.0; the TTM figure through Dec 2016 stood at -$168176.0 (changed N/A YoY), while the FY2017 annual figure was $10528.0, up 106.26% from the prior year.
- Gains from Investment Securities came in at -$2335.0 for Q4 2016 at CareView Communications, up from -$8821.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of -$2335.0 in Q4 2016 to a low of -$98779.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | -2,335.00 |
| Sep 30, 2016 | -8,821.00 |
| Jun 30, 2016 | -72,523.00 |
| Mar 31, 2016 | -84,497.00 |
| Dec 31, 2015 | -98,779.00 |
| Sep 30, 2015 | -47,234.00 |